PURA Confirms $4 Million 2019 Revenue Target On Growing Demand For EVERx CBD Sports Water
May 22 2019 - 12:07PM
InvestorsHub NewsWire
PURA Confirms $4 Million 2019
Revenue Target On Growing Demand For EVERx CBD Sports Water
DALLAS, TX
-- May 22, 2019 -- InvestorsHub NewsWire -- Puration, Inc.
(USOTC:
PURA) today confirmed management’s recent $4 million 2019
revenue target on growing demand for its cornerstone EVERx CBD
Sports Water product. The company just posted its 2019 Q1
financial report demonstrating over a $1 million base annual
revenue run rate. The company also has a new $1.5 million
order to produce private labeled CBD water which is not yet
reflected in the company’s financial statement. Demand for
EVERx has strained the company’s current production capacity, but a
second production facility is anticipated to be online by the end
of June. With expanded production, management may consider
revising its 2019 revenue target upwards later this year. In
addition to the $3 million in CBD beverage sales anticipated this
year at the current production capacity, management is targeting an
additional $1 million in sales from new cannabis beverage sales the
company is currently in the process of launching. The overall
basic sales target for 2019 is currently $4
million.
PURA
management believes the recent flurry of inquiries into company
exploring the possibility of a cannabis beverage merger with one or
more other cannabis beverage companies is a validation of PURA’s
success in establishing EVERx as a valuable CBD brand name.
Next week, management will publish an update with more details on
the company’s 2019 sales projections to include an update on what
the growing cannabis beverage merger and acquisition market
interest might mean for PURA. Finally, the presentation next
week will include a update on the impending dividend Nouveau
(USOTC:
NOUV) to PURA shareholders.
PURA
Shareholder Dividend
PURA
management has recently updated its approach with NOUV to deliver
on the dividend of NOUV stock to PURA shareholders in conjunction
with the 2018 Q4 spinoff of PURA’s cannabis cultivation operation
to NOUV. A new website facilitating the acceleration of the
dividend issuance process is to be launched imminently. In
conjunction with the launch, PURA and NOUV management will detail
the role of the website and further details with the updated
dividend issuance strategy.
For more
information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Mar 2023 to Mar 2024